Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about MYELINATION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
MYELINATION is a concept in neurodegeneration research. Key relationships include: co discussed, impairs, expressed in. Associated with ALZHEIMER, ALZHEIMER'S, ALZHEIMER'S DISEASE. Connected to 57 entities in the SciDEX knowledge graph.
No AI portrait yet
| Name | MYELINATION |
| Key Genes/Proteins | APOE4 |
Knowledge base pages for this entity
graph TD
MYELINATION["MYELINATION"]
HDAC7["HDAC7"] -->|"regulates"| MYELINATION
AQP4["AQP4"] -->|"activates"| MYELINATION
CD19["CD19"] -->|"target for"| MYELINATION
GPR37["GPR37"] -->|"inhibits"| MYELINATION
CR2["CR2"] -->|"inhibits"| MYELINATION
OVERVIEW["OVERVIEW"] -->|"inhibits"| MYELINATION
SOD1["SOD1"] -->|"regulates"| MYELINATION
GFAP["GFAP"] -->|"activates"| MYELINATION
COMPLEMENT["COMPLEMENT"] -->|"causes"| MYELINATION| Target | Relation | Type | Str |
|---|---|---|---|
| RNA | regulates | gene | 0.60 |
| SREBF2 | regulates | gene | 0.60 |
| NEURON | co_discussed | entity | 0.50 |
| OLIGODENDROCYTE | co_discussed | entity | 0.50 |
| OLIGODENDROCYTES | co_discussed | entity | 0.50 |
| STING | co_discussed | entity | 0.50 |
| REMYELINATION | co_discussed | entity | 0.50 |
| NEURONS | co_discussed | entity | 0.50 |
| GENE EXPRESSION | regulates | concept | 0.50 |
| MYELIN | protects_against | concept | 0.50 |
| DEMYELINATION | protects_against | concept | 0.50 |
| Spinal Cord | activates | cell_type | 0.50 |
| OLIGODENDROCYTES | activates | concept | 0.50 |
| disease | inhibits | disease | 0.50 |
| White Matter | inhibits | process | 0.50 |
| NEURODEGENERATIVE DISEASE | inhibits | concept | 0.50 |
| Spinal Cord | inhibits | cell_type | 0.50 |
| OLIGODENDROCYTES | regulates | concept | 0.50 |
| AXON | expressed_in | concept | 0.50 |
| T Cell | associated_with | cell_type | 0.50 |
| VESICLE TRAFFICKING | activates | concept | 0.50 |
| Proteins | associated_with | protein | 0.50 |
| MYELIN | causes | concept | 0.50 |
| OLIGODENDROCYTES | causes | concept | 0.50 |
| MYELIN | expressed_in | concept | 0.50 |
| Epilepsy | associated_with | disease | 0.50 |
| Oligodendrocyte | associated_with | cell_type | 0.50 |
| Stem Cell | associated_with | cell_type | 0.50 |
| Astrocyte | associated_with | cell_type | 0.50 |
| Neural Stem Cell | associated_with | cell_type | 0.50 |
| Neuron | associated_with | cell_type | 0.50 |
| PHAGOCYTOSIS | co_discussed | entity | 0.50 |
| WHITE MATTER | co_discussed | entity | 0.50 |
| SPHINGOLIPID | co_discussed | entity | 0.50 |
| SPINAL CORD | co_discussed | entity | 0.50 |
| TDP-43 | co_discussed | entity | 0.50 |
| SYNAPTIC PLASTICITY | co_discussed | entity | 0.50 |
| SEEDING | co_discussed | entity | 0.50 |
| UNFOLDED PROTEIN RESPONSE | co_discussed | entity | 0.50 |
| STROKE | co_discussed | entity | 0.50 |
| SLEEP | co_discussed | entity | 0.50 |
| TAU | co_discussed | entity | 0.50 |
| PARKINSON | co_discussed | entity | 0.50 |
| PARKINSON'S | co_discussed | entity | 0.50 |
| PSP | co_discussed | entity | 0.50 |
| AXON | protects_against | entity | 0.50 |
| STAT3 | co_discussed | entity | 0.50 |
| SREBF2 | co_discussed | entity | 0.50 |
| AXON | activates | concept | 0.50 |
| NEURODEGENERATION | causes | entity | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Iron | involved_in | compound | 0.95 |
| APOE4 | associated_with | gene | 0.95 |
| OCN | inhibits | protein | 0.95 |
| Cholesterol Dysregulation | inhibits | mechanism | 0.90 |
| APOE4 | impairs | gene | 0.90 |
| Microglia Activation | regulates | process | 0.85 |
| GBA1 | regulates | gene | 0.80 |
| HDAC7 | regulates | protein | 0.80 |
| Microglia | regulates | cell_type | 0.80 |
| COMPLEMENT | causes | gene | 0.60 |
| AQP4 | causes | gene | 0.60 |
| ASTROCYTES | causes | gene | 0.60 |
| CD19 | causes | gene | 0.60 |
| ASTROCYTE | causes | gene | 0.60 |
| NEUROINFLAMMATION | causes | gene | 0.60 |
| C9ORF72 | interacts_with | gene | 0.60 |
| INFLAMMATION | causes | gene | 0.60 |
| SOD1 | interacts_with | gene | 0.60 |
| NEURODEGENERATIVE DISORDERS | contributes_to | gene | 0.60 |
| AMYOTROPHIC LATERAL SCLEROSIS | regulates | gene | 0.60 |
| VEGF | expressed_in | gene | 0.60 |
| SOD1 | contributes_to | gene | 0.60 |
| MICROGLIA | associated_with | gene | 0.60 |
| STROKE | associated_with | gene | 0.60 |
| AQUAPORIN-4 | causes | gene | 0.60 |
| OVERVIEW | activates | gene | 0.60 |
| PHAGOCYTOSIS | activates | gene | 0.60 |
| TNF | expressed_in | gene | 0.60 |
| GABRA1 | causes | gene | 0.60 |
| AMYOTROPHIC LATERAL SCLEROSIS | contributes_to | gene | 0.60 |
| C4B | associated_with | gene | 0.60 |
| OVERVIEW | inhibits | gene | 0.60 |
| CYTOKINES | activates | gene | 0.60 |
| JUN | associated_with | gene | 0.60 |
| OPTN | associated_with | gene | 0.60 |
| COMPLEMENT | inhibits | gene | 0.60 |
| CYTOKINES | inhibits | gene | 0.60 |
| NEURODEGENERATION | activates | gene | 0.60 |
| SOD1 | regulates | gene | 0.60 |
| EPILEPSY | causes | gene | 0.60 |
| INFLAMMATION | regulates | gene | 0.60 |
| OPTINEURIN | regulates | gene | 0.60 |
| APOE | regulates | gene | 0.60 |
| GABRG2 | causes | gene | 0.60 |
| GENES | causes | gene | 0.60 |
| IL-6 | expressed_in | gene | 0.60 |
| BANG | activates | gene | 0.60 |
| ASTROCYTE | associated_with | gene | 0.60 |
| TREM2 | associated_with | gene | 0.60 |
| RIPK1 | associated_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Oligodendrocyte Remyelination Enhancement | 0.644 | neurodegeneration | Gene expression changes in aging mouse b |
| MOG-IgG induces spinal cord demyelination through Fcγ recept | 0.560 | neuroinflammation | What are the specific pathophysiological |
| BMP4 Pathway Inhibition for Oligodendrocyte Myelination Supp | 0.536 | neurodegeneration | Cell type vulnerability in Alzheimer's D |
| Oligodendrocyte Lineage Vulnerability: Early Myelination Dis | 0.530 | neurodegeneration | Cell type vulnerability debate in Alzhei |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| cGAMP Enhances Microglial/Macrophage Phagocytosis in Ischemic Stroke Via Activat [PMID:41495583] | ["Li Xinyu", "Ding Huamin", "Qian Shuyu" | Inflammation | 2026 | 0 |
| The gain-of-function TREM2-T96K mutation increases risk for Alzheimer's disease [PMID:41109213] | Pilat DJ, Le H, Prokopenko D, Lin CJ, Ei | Neuron | 2026 | 0 |
| Role of TREM2 in neuroinflammation. [PMID:41213496] | Abdulkhaliq AA, Alasiri G, Almoghrabi Y, | Exp Neurol | 2026 | 0 |
| Fusion of Tumor Cells with Lipid-Associated Macrophages Drives Metastatic Progre [PMID:41342370] | Cheng Y, Huang G, Liu X, Wu C, Lian J et | Cancer Res | 2026 | 0 |
| ANGPTL4 regulates the adipogenic-osteogenic differentiation balance of bone marr [PMID:41482017] | Huang F, Zhu Z, Xing Q, Li M | Biochimie | 2026 | 0 |
| Targeting senescent EGR1(+) B cells enhances immunotherapy efficacy in esophagea [PMID:41483805] | Zhou P, Zhang Y, Zhang H, Zhao P, Guo Y | Cell Rep Med | 2026 | 0 |
| Synergistic potential of TREM2 agonists and exercise training in Alzheimer's dis [PMID:41494649] | Zhang J, St Pierre Schneider B, Muguerza | Am J Physiol Endocrinol Metab | 2026 | 0 |
| Peripheral cancer attenuates amyloid pathology in Alzheimer's disease via cystat [PMID:41576952] | Li X, Tang X, Zeng J, Duan L, Hou Z et a | Cell | 2026 | 0 |
| TREM2 expression level is critical for microglial state, metabolic capacity and [PMID:41580393] | Feiten AF, Dahm K, Schlepckow K, van Len | Nat Commun | 2026 | 0 |
| TREM2 and microglial immunity in Alzheimer's disease: mechanisms, genetics, and [PMID:41789102] | Wang T, Liu X, Wang X, Hua F, Yan L | Front Immunol | 2026 | 0 |
| TREM2 in neurodegeneration and diseases. [PMID:41792456] | ["Abdulkhaliq A", "Alasiri G", "Kim B", | Molecular psychiatry | 2026 | 0 |
| Alzheimer's Disease as a Disorder of Neuroimmune Dysregulation. [PMID:41745721] | Aranda-Abreu GE, Rojas-Durán F, Hernánde | Neurology international | 2026 | 0 |
| Molecular mechanism of Alzheimer's disease using integrated multi-omics. [PMID:41907842] | Alhusaini M, Mussa BM, Ilce BY, Alhaj H, | Frontiers in aging neuroscienc | 2026 | 0 |
| Viral and non-viral cellular therapies for neurodegeneration. [PMID:41585268] | ["Srivastav Jyotsna", "Sharma Sachin"] | Frontiers in medicine | 2025 | 0 |
| BMP4 dose dictates lineage specification bias in human periodontal ligament stem [PMID:41568233] | Li Y, Tang Q, Li L, Lin C, Guo M et al. | Front Bioeng Biotechnol | 2025 | 0 |
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning MYELINATION in their description or question text
No additional research found